Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.
Pancreatic cancer research, clinical trials supported with $10.9 million NCI grant (Links to an external site)
